ACTIV-6: COVID-19 Study of Repurposed Medications
Study at a Glance
Estimated Time Commitment
Study entirely virtual, length of time taking study medications is dependent on which medication is being used (up to 14 days). Online symptom surveys daily until symptoms go away; phone contacts at Day 14, 21, 28 and 90.Eligibility
Age ≥ 30 years; 2 or more symptoms of acute COVID for ≤ 7 days, positive COVID test within 10 days; not needing hospitalization for current infection
Diagnosis Required
Active acute COVID-19Diseases Being Studied
Mild to Moderate Acute COVID-19 infection.Gov identifier: NCT04885530, study is testing different medications that are already approved for other indications to see if they help people with mild to moderate COVID feel better faster.
Interested in Participating?
Sign up to be contacted for more information.
Meet Your Clinical Research Team
Contact us
Principal Investigator: Local PI: Thomas Patterson, M.D.For more information, please contact Dr. Thomas Patterson at patterson@uthscsa.edu